Interventional pain management or interventional pain medicine is a medical subspecialty defined by the National Uniforms Claims Committee (NUCC) as " invasive interventions such as the discipline of medicine devoted to the diagnosis and treatment of pain related disorders principally with the application of interventional techniques in managing sub acute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment". Medicare Payment Advisory Commission (MedPAC) defined interventional techniques as "minimally invasive procedures including, percutaneous precision needle placement, with placement of drugs in targeted areas or ablation of targeted nerves; and some surgical techniques such as laser or endoscopic diskectomy, intrathecal infusion pumps and spinal cord stimulators, for the diagnosis and management of chronic, persistent or intractable pain". Minimally invasive interventions, such as facet joint injections, nerve blocks (interrupting the flow of pain signals along specific nerve pathways), neuroaugmentation (including spinal cord stimulation and peripheral nerve stimulation), vertebroplasty, kyphoplasty, nucleoplasty, endoscopic discectomy, and implantable drug delivery systems are utilized in managing subacute or chronic pain.
History Early efforts at interventional pain management date back to the origins of regional analgesia and nerve blocks, and gradually evolved into a distinct specialty. Tuffer described the first therapeutic nerve block for pain management in 1899. Von Gaza developed diagnostic blockade in pain management, using procaine for determining the pain's pathways. Modern-day contributors include Bonica, Winnie, Raj, Racz, Bogduk, and others. The term "interventional pain management" was first used by pain management specialist Steven D. Waldman in 1996 to define the emerging specialty. The subspecialty of interventional pain management has received a specific specialty designation by the United States National Uniform Billing Committee to allow its practitioners to bill federal healthcare programs, including Medicare and Medicaid. Physicians who practice interventional pain management are represented by a variety of pain management organizations, including the American Society of Interventional Pain Physicians (ASIPP), founded by Laxmaiah Manchikanti in 1998, which solely represents interventional pain management professionals.
Nerve blocks
Nerve blocks involve the injection of local anesthetics, corticosteroids, or neurolytic agents near specific nerves or nerve bundles to disrupt pain signal transmission. Commonly performed nerve blocks include celiac plexus block for visceral and cancer pain, stellate ganglion block for sympathetically mediated upper extremity pain, medial branch block for facet joint pain, and greater occipital nerve block for cervicogenic headaches and occipital neuralgia. Procedures may be performed under fluoroscopic or ultrasound guidance to improve precision and reduce risk. When used diagnostically, nerve blocks help identify the source of pain; as a therapeutic modality, repeated blocks may provide cumulative long-term relief.
Radiofrequency ablation
Radiofrequency ablation (RFA) uses radiofrequency waves to generate heat and selectively destroy nerve tissue responsible for transmitting pain signals. A needle-electrode is positioned near the target nerve under fluoroscopic or ultrasound guidance; application of radiofrequency energy thermally ablates the nerve, with pain relief typically lasting from several months to years. RFA is widely employed for facet joint–mediated axial back pain, sacroiliac joint pain, chronic knee pain, and trigeminal neuralgia. Pulsed radiofrequency (PRF), a variant that uses intermittent rather than continuous current, modulates nerve function without thermal destruction and is applied for neuropathic conditions such as radiculopathy and postherpetic neuralgia.
Platelet-rich plasma
Platelet-rich plasma (PRP) therapy concentrates growth factors from a patient's own blood and injects them into injured or degenerated musculoskeletal structures. The alpha granules of platelets contain platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and vascular endothelial growth factor (VEGF), which are believed to promote tissue regeneration and modulate chronic inflammation. PRP injections are used in interventional pain management for knee osteoarthritis, chronic rotator cuff tendinopathy, lateral epicondylitis, and discogenic back pain.
Radiation Radiotherapy is used when drug treatment is failing to control the pain of a growing tumor, such as in bone metastasis (most commonly), penetration of soft tissue, or compression of sensory nerves. Often, low doses are adequate to produce analgesia, thought to be due to a reduction in pressure or, possibly, interference with the tumor's production of pain-promoting chemicals. Radiopharmaceuticals that target specific tumors have been used to treat the pain of metastatic illnesses. Relief may occur within a week of treatment and may last from two to four months.
Neurolytic block
A neurolytic block is the deliberate injury of a nerve by the application of chemicals (in which case the procedure is called "neurolysis") or physical agents such as freezing or heating ("neurotomy"). These interventions cause degeneration of the nerve's fibers and temporary interference with the transmission of pain signals. In these procedures, the thin protective layer around the nerve fiber, the basal lamina, is preserved so that, as a damaged fiber regrows, it travels within its basal lamina tube and connects with the correct loose end, and function may be restored. Surgically cutting a nerve severs these basal lamina tubes, and without them to channel the regrowing fibers to their lost connections, a painful neuroma or deafferentation pain may develop. This is why the neurolytic is preferred over the surgical block.
Cutting or destruction of nervous tissue
… excerpt ends here. Continue reading the full article.


